A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy. BJU Int. 2005 Oct; 96(6):787-90.